These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29066722)

  • 21. Bcl-XL mediates epidermal growth factor dependent cell survival in HC11 mammary epithelial cells.
    Romorini L; Coso OA; Pecci A
    Biochim Biophys Acta; 2009 Mar; 1793(3):496-505. PubMed ID: 19121340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A cytoskeleton-based functional genetic screen identifies Bcl-xL as an enhancer of metastasis, but not primary tumor growth.
    Martin SS; Ridgeway AG; Pinkas J; Lu Y; Reginato MJ; Koh EY; Michelman M; Daley GQ; Brugge JS; Leder P
    Oncogene; 2004 Jun; 23(26):4641-5. PubMed ID: 15064711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bcl-xL mediates therapeutic resistance of a mesenchymal breast cancer cell subpopulation.
    Keitel U; Scheel A; Thomale J; Halpape R; Kaulfuß S; Scheel C; Dobbelstein M
    Oncotarget; 2014 Dec; 5(23):11778-91. PubMed ID: 25473892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells.
    Wang Y; Niu XL; Qu Y; Wu J; Zhu YQ; Sun WJ; Li LZ
    Cancer Lett; 2010 Sep; 295(1):110-23. PubMed ID: 20236757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct apoptotic blocks mediate resistance to panHER inhibitors in HER2+ breast cancer cells.
    Karakas B; Ozmay Y; Basaga H; Gul O; Kutuk O
    Biochim Biophys Acta Mol Cell Res; 2018 Aug; 1865(8):1073-1087. PubMed ID: 29733883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bcl-2 and Bcl-xL mediate resistance to receptor tyrosine kinase-targeted therapy in lung and gastric cancer.
    Jin J; Xiong Y; Cen B
    Anticancer Drugs; 2017 Nov; 28(10):1141-1149. PubMed ID: 28885267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
    Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
    Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HOXC8 regulates self-renewal, differentiation and transformation of breast cancer stem cells.
    Shah M; Cardenas R; Wang B; Persson J; Mongan NP; Grabowska A; Allegrucci C
    Mol Cancer; 2017 Feb; 16(1):38. PubMed ID: 28202042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gefitinib induction of in vivo detectable signals by Bcl-2/Bcl-xL modulation of inositol trisphosphate receptor type 3.
    Zannetti A; Iommelli F; Fonti R; Papaccioli A; Sommella J; Lettieri A; Pirozzi G; Bianco R; Tortora G; Salvatore M; Del Vecchio S
    Clin Cancer Res; 2008 Aug; 14(16):5209-19. PubMed ID: 18698039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bcl-xL is overexpressed in hormone-resistant prostate cancer and promotes survival of LNCaP cells via interaction with proapoptotic Bak.
    Castilla C; Congregado B; Chinchón D; Torrubia FJ; Japón MA; Sáez C
    Endocrinology; 2006 Oct; 147(10):4960-7. PubMed ID: 16794010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
    Henkels KM; Turchi JJ
    Cancer Res; 1999 Jul; 59(13):3077-83. PubMed ID: 10397248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NF-κB activation fails to protect cells to TNFα-induced apoptosis in the absence of Bcl-xL, but not Mcl-1, Bcl-2 or Bcl-w.
    Casanelles E; Gozzelino R; Marqués-Fernández F; Iglesias-Guimarais V; Garcia-Belinchón M; Sánchez-Osuna M; Solé C; Moubarak RS; Comella JX; Yuste VJ
    Biochim Biophys Acta; 2013 May; 1833(5):1085-95. PubMed ID: 23369735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells.
    Arisan ED; Kutuk O; Tezil T; Bodur C; Telci D; Basaga H
    Breast Cancer Res Treat; 2010 Jan; 119(2):271-81. PubMed ID: 19238538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of Bcl-xL in human breast cancer cells enhances organ-selective lymph node metastasis.
    España L; Fernández Y; Rubio N; Torregrosa A; Blanco J; Sierra A
    Breast Cancer Res Treat; 2004 Sep; 87(1):33-44. PubMed ID: 15377849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic delivery of siRNA specific to tumor mediated by atelocollagen: combined therapy using siRNA targeting Bcl-xL and cisplatin against prostate cancer.
    Mu P; Nagahara S; Makita N; Tarumi Y; Kadomatsu K; Takei Y
    Int J Cancer; 2009 Dec; 125(12):2978-90. PubMed ID: 19422046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
    Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The N-terminus and alpha-5, alpha-6 helices of the pro-apoptotic protein Bax, modulate functional interactions with the anti-apoptotic protein Bcl-xL.
    Parikh N; Koshy C; Dhayabaran V; Perumalsamy LR; Sowdhamini R; Sarin A
    BMC Cell Biol; 2007 May; 8():16. PubMed ID: 17519046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A targeted proteomics approach to the quantitative analysis of ERK/Bcl-2-mediated anti-apoptosis and multi-drug resistance in breast cancer.
    Yang T; Xu F; Sheng Y; Zhang W; Chen Y
    Anal Bioanal Chem; 2016 Oct; 408(26):7491-503. PubMed ID: 27510278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fractalkine/CX3CR1 induces apoptosis resistance and proliferation through the activation of the AKT/NF-κB cascade in pancreatic cancer cells.
    Wang H; Cai J; Du S; Guo Z; Xin B; Wang J; Wei W; Shen X
    Cell Biochem Funct; 2017 Aug; 35(6):315-326. PubMed ID: 28845524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bcl-xL is expressed in ovarian carcinoma and modulates chemotherapy-induced apoptosis.
    Liu JR; Fletcher B; Page C; Hu C; Nunez G; Baker V
    Gynecol Oncol; 1998 Sep; 70(3):398-403. PubMed ID: 9790794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.